lysine has been researched along with Agnogenic Myeloid Metaplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, K; Furukawa, Y; Harada, H; Iwama, A; Kaneda, A; Koide, S; Koseki, H; Nakajima-Takagi, Y; Oshima, M; Rahmutulla, B; Saraya, A; Sashida, G; Shimoda, K; Shinoda, D; Tanaka, T; Yamaguchi, K | 1 |
| Gill, H | 1 |
| Barosi, G; Campanelli, R; Catarsi, P; Massa, M; Poletto, V; Rosti, V; Vannucchi, AM; Villani, L | 1 |
1 review(s) available for lysine and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Lysine-Specific Demethylase 1 (LSD1/KDM1A) Inhibition as a Target for Disease Modification in Myelofibrosis.
Topics: Hematopoietic Stem Cell Transplantation; Histone Demethylases; Humans; Lysine; Myeloproliferative Disorders; Primary Myelofibrosis | 2022 |
2 other study(ies) available for lysine and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis.
Topics: Animals; Cell Differentiation; Female; Janus Kinase 2; Lysine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Polycomb Repressive Complex 1; Primary Myelofibrosis; Ubiquitination | 2022 |
No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis.
Topics: Cell Transformation, Neoplastic; Cohort Studies; Genetic Variation; Glutamine; Humans; Leukemia, Myeloid, Acute; Lysine; Phenotype; Polymorphism, Genetic; Primary Myelofibrosis; Xeroderma Pigmentosum Group D Protein | 2013 |